Novo Nordisk to switch to 100% renewable electricity
Novo Nordisk plans to switch all its production plants worldwide to renewable energy, including wind, by 2020.
Novo Nordisk plans to switch all its production plants worldwide to renewable energy, including wind, by 2020.
Teva has teamed with Heptares to develop and commercialise easily-deliverable small-molecule calcitonin gene-related peptide (CGPR) antagonists to treat migraine.
The number of pharmaceutical cargo thefts has fallen in recent years, but manufacturers still need to be vigilant according to an expert who says the holidays are a risky period.
Preclinical CRO Biopta will add stem cell programming tech to its offering, expand in Japan and nearly double its workforce under new owner, Reprocell.
PCT Europe 2015
Big Pharma bureaucracy makes trials less efficient but listening to CRO partners can help reverse this, say experts from Pfizer, Bayer and Grunenthal.
New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck*.